VINC

3.05% -0.0004

시간 외 거래: .01 -0.0027 -21.26%

Vincerx Pharma Inc (VINC)

개요 뉴스 가격 이력 Financials 토론 예측

Relative Volume:

Vincerx Pharma Inc Stock (VINC) Company Profile

Vincerx Pharma Inc

Healthcare (1104)

Biotechnology (617)

최신 SEC 제출 서류

VINC's Discussions on Twitter

Compare VINC vs VRTX, REGN, ARGX, ALNY, RVMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
VINC Vincerx Pharma Inc	0.0127	0	0	-22.65M	-22.84M	-5.1849
VRTX Vertex Pharmaceuticals Inc	451.63	116.49B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	609.94	63.73B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.72	55.49B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	278.09	37.75B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	162.99	33.54B	742.00K	-1.37B	-1.07B	-7.0731

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-01-14	개시	H.C. Wainwright	Buy
2021-12-23	개시	Cantor Fitzgerald	Overweight
2021-11-01	개시	SVB Leerink	Outperform
2021-09-13	개시	Laidlaw	Buy
2021-08-25	개시	B. Riley Securities	Buy

Vincerx Pharma Inc 주식(VINC)의 최신 뉴스

Vincerx Pharma Inc (VINC) 재무 분석

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc Stock (VINC) Company Profile

Compare VINC vs VRTX, REGN, ARGX, ALNY, RVMD

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Vincerx Pharma Inc 주식(VINC)의 최신 뉴스

Why Is Vincerx Pharma, Inc. (VINCU) Stock Down Today? - Meyka

Drug Transport Company Sued by Insurer Over Destroyed-Cells Case - Bloomberg Law News

VINC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Head to Head Comparison: Ampio Pharmaceuticals (NYSE:AMPE) & Vincerx Pharma (NASDAQ:VINC) - Defense World

Contrasting Vincerx Pharma (NASDAQ:VINC) and iBio (NYSE:IBIO) - Defense World

Critical Review: Vincerx Pharma (NASDAQ:VINC) & Trevena (NASDAQ:TRVN) - Defense World

Reviewing Leap Therapeutics (NASDAQ:LPTX) and Vincerx Pharma (NASDAQ:VINC) - Defense World

Analyzing Vincerx Pharma (NASDAQ:VINC) & Petros Pharmaceuticals (NASDAQ:PTPI) - Defense World

Head to Head Analysis: Vectura Group (OTCMKTS:VEGPF) and Vincerx Pharma (NASDAQ:VINC) - Defense World

Vincerx Pharma, Inc. Announces Additional Adjournment of - GlobeNewswire

Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders - The Manila Times

Vincerx Pharma | DEFA14A: Others - Moomoo

Global Digital Holdings Inc. cancelled the acquisition of Vincerx Pharma, Inc. in a reverse merger transaction. - marketscreener.com

VINC: Vincerx Pharma to dissolve, with minimal or no distributions expected for stockholders - TradingView

VINC Stock Price, News & Analysis - Stock Titan

VINC Stock Price and Chart — OTC:VINC - TradingView

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com

Nasdaq to delist Vincerx Pharma by April 23 - Investing.com Australia

Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan

vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India

vincerx pharma cancels merger, initiates wind-down activities - Investing.com

Vincerx prepares to wind down as final merger attempt collapses - Fierce Biotech

Financially struggling drugmaker's potential rescue falls apart. It now will wind down - The Business Journals

Vincerx Pharma Inc. (VINC) reports earnings - qz.com

Vincerx, left in limbo by collapsed deal, moves to merge with AI company to escape cash crisis - Fierce Biotech

Cash-strapped Vincerx left mulling future after Oqory reverse merger falls apart - Fierce Biotech

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - Yahoo Finance

Vincerx Pharma, Oqory highlight Phase 1a/1b data for OQY-3258 - TipRanks

Vincerx Pharma, Inc. Announces 1-for-20 Reverse Stock Split Effective January 27, 2025 - Nasdaq

Vincerx Pharma, Inc. Announces Reverse Stock Split - The Manila Times

Vincerx Pharma enters at-the-market equity offering deal - Investing.com

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders - Finansavisen

Chutes & Ladders—Vincerx acquisition leads to C-suite shake-up - Fierce Biotech

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish - Asianet Newsable

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - Yahoo Finance

Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials - Asianet Newsable

ARMISTICE CAPITAL, LLC Expands Stake in Vincerx Pharma Inc - GuruFocus

Prosight Management, LP Reduces Stake in Vincerx Pharma Inc - GuruFocus

Vincerx Pharma Inc (VINC) Quarterly 10-Q Report - qz.com

What Makes Vincerx Pharma (VINC) a New Buy Stock - Yahoo Finance

VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges - Investing.com

Vincerx Reports Positive Initial Clinical Data from Ongoing - GlobeNewswire

Vincerx Pharma (NASDAQ: VINCU)Share Price - intelligentinvestor.com.au

Vincerx Pharma Reports Second Quarter 2024 Financial Results - GlobeNewswire

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - Investing News Network

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - Investing News Network

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants By Investing.com - Investing.com India

Vincerx Blames Stock Plunge On Overheated ADC Expectations - Citeline News & Insights

Why Is Vincerx Pharma (VINC) Stock Down 64% Today? - InvestorPlace

Vincerx Pharma Presents Positive Preliminary Phase 1 Data - GlobeNewswire

Vincerx Pharma Inc (VINC) 재무 분석

매출

순이익

현금흐름

주당 순 이익

VINC과 유사한 종목